These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20670680)

  • 1. Translation of novel anti-cancer cytotoxicity biomarkers detected with high content analysis from an in vitro predictive model to an in vivo cell model.
    Lieggi NT; Edvardsson A; O'Brien PJ
    Toxicol In Vitro; 2010 Dec; 24(8):2063-71. PubMed ID: 20670680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-content analysis in toxicology: screening substances for human toxicity potential, elucidating subcellular mechanisms and in vivo use as translational safety biomarkers.
    O'Brien PJ
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):4-17. PubMed ID: 24641563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs.
    Li W; Lam M; Choy D; Birkeland A; Sullivan ME; Post JM
    Toxicol In Vitro; 2006 Aug; 20(5):669-76. PubMed ID: 16289493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring and modeling of binary mixture effects of pharmaceuticals and nickel on cell viability/cytotoxicity in the human hepatoma derived cell line HepG2.
    Rudzok S; Schlink U; Herbarth O; Bauer M
    Toxicol Appl Pharmacol; 2010 May; 244(3):336-43. PubMed ID: 20132835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
    Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
    Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bioavailability on the correlation between in vitro cytotoxic and in vivo acute fish toxic concentrations of chemicals.
    Gülden M; Seibert H
    Aquat Toxicol; 2005 May; 72(4):327-37. PubMed ID: 15848252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms.
    Zhang R; Niu Y; Zhou Y
    Toxicol Lett; 2010 Feb; 192(2):108-14. PubMed ID: 19853026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements.
    Beckers S; Noor F; Müller-Vieira U; Mayer M; Strigun A; Heinzle E
    Toxicol In Vitro; 2010 Mar; 24(2):686-94. PubMed ID: 19427895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocyte cultures.
    Rawlinson LA; O'Brien PJ; Brayden DJ
    J Control Release; 2010 Aug; 146(1):84-92. PubMed ID: 20457190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model.
    Edling Y; Sivertsson LK; Butura A; Ingelman-Sundberg M; Ek M
    Toxicol In Vitro; 2009 Oct; 23(7):1387-95. PubMed ID: 19631733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells.
    Florea AM; Büsselberg D
    Toxicol Lett; 2008 Jun; 179(1):34-42. PubMed ID: 18485628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel, physiologically relevant cytotoxicity model: application to the study of chemotherapeutic damage to mesenchymal stromal cells.
    May JE; Morse HR; Xu J; Donaldson C
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):374-89. PubMed ID: 22835568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.